Matches in SemOpenAlex for { <https://semopenalex.org/work/W2141796183> ?p ?o ?g. }
- W2141796183 endingPage "1464" @default.
- W2141796183 startingPage "1453" @default.
- W2141796183 abstract "Abstract A library of new anthranilamide–pyrazolo[1,5‐ a ]pyrimidine conjugates were designed, synthesized, and evaluated for their anticancer activity in cervical cancer cells such as HeLa and SiHa that possess low levels of p53. All 24 conjugates showed antiproliferative activity, while some of them exhibit significant cytotoxicity. In assays related to cell‐cycle distribution, these conjugates induced G 2 /M arrest in HeLa cells and G 1 cell‐cycle arrest in SiHa cells. Immunocytochemistry assays revealed that these compounds cause nuclear translocation of p53, thereby indicating the activation of p53. In cervical cancer cells, the p53 protein is degraded by E6 oncoprotein. Immunoblot and RT‐PCR analyses proved the presence of mitochondria‐mediated apoptosis with involvement p53 target genes such as BAX, Bcl2, and p21 (CDKI). Moreover, these compounds increased the phosphorylated forms of p53 and provide signals for apoptosis induction. Interestingly, one of the conjugates, (2‐phenyl‐7‐(3,4,5‐trimethoxyphenyl)pyrazolo[1,5‐ a ]pyrimidin‐5‐yl)(4‐(2‐(thiophen‐2‐ylmethylamino)benzoyl)piperazin‐1‐yl)methanone, is the most promising candidate in this series and has the potential to be taken up for further detailed studies." @default.
- W2141796183 created "2016-06-24" @default.
- W2141796183 creator A5012840594 @default.
- W2141796183 creator A5015141642 @default.
- W2141796183 creator A5028889608 @default.
- W2141796183 creator A5029531283 @default.
- W2141796183 creator A5030586237 @default.
- W2141796183 creator A5050526230 @default.
- W2141796183 creator A5060629326 @default.
- W2141796183 creator A5063941329 @default.
- W2141796183 creator A5083162341 @default.
- W2141796183 date "2012-06-14" @default.
- W2141796183 modified "2023-10-10" @default.
- W2141796183 title "Anthranilamide-Pyrazolo[1,5-a]pyrimidine Conjugates as p53 Activators in Cervical Cancer Cells" @default.
- W2141796183 cites W1494491432 @default.
- W2141796183 cites W1566271574 @default.
- W2141796183 cites W1964374289 @default.
- W2141796183 cites W1971691812 @default.
- W2141796183 cites W1981169729 @default.
- W2141796183 cites W1985411236 @default.
- W2141796183 cites W1991030274 @default.
- W2141796183 cites W1997892364 @default.
- W2141796183 cites W2008193634 @default.
- W2141796183 cites W2020540085 @default.
- W2141796183 cites W2024680115 @default.
- W2141796183 cites W2028853828 @default.
- W2141796183 cites W2036097345 @default.
- W2141796183 cites W2039382131 @default.
- W2141796183 cites W2039771541 @default.
- W2141796183 cites W2042740031 @default.
- W2141796183 cites W2045300715 @default.
- W2141796183 cites W2045689757 @default.
- W2141796183 cites W2046107124 @default.
- W2141796183 cites W2053372213 @default.
- W2141796183 cites W2054146719 @default.
- W2141796183 cites W2060536206 @default.
- W2141796183 cites W2062541888 @default.
- W2141796183 cites W2078241183 @default.
- W2141796183 cites W2082399676 @default.
- W2141796183 cites W2097786201 @default.
- W2141796183 cites W2109545571 @default.
- W2141796183 cites W2122028337 @default.
- W2141796183 cites W2124617257 @default.
- W2141796183 cites W2150508157 @default.
- W2141796183 cites W2172905429 @default.
- W2141796183 cites W2174067184 @default.
- W2141796183 cites W2175404475 @default.
- W2141796183 cites W2179928471 @default.
- W2141796183 cites W2180456532 @default.
- W2141796183 cites W2180601528 @default.
- W2141796183 cites W2314303292 @default.
- W2141796183 cites W2325707043 @default.
- W2141796183 cites W2950740969 @default.
- W2141796183 doi "https://doi.org/10.1002/cmdc.201200205" @default.
- W2141796183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22700474" @default.
- W2141796183 hasPublicationYear "2012" @default.
- W2141796183 type Work @default.
- W2141796183 sameAs 2141796183 @default.
- W2141796183 citedByCount "11" @default.
- W2141796183 countsByYear W21417961832013 @default.
- W2141796183 countsByYear W21417961832014 @default.
- W2141796183 countsByYear W21417961832015 @default.
- W2141796183 countsByYear W21417961832017 @default.
- W2141796183 countsByYear W21417961832021 @default.
- W2141796183 countsByYear W21417961832022 @default.
- W2141796183 crossrefType "journal-article" @default.
- W2141796183 hasAuthorship W2141796183A5012840594 @default.
- W2141796183 hasAuthorship W2141796183A5015141642 @default.
- W2141796183 hasAuthorship W2141796183A5028889608 @default.
- W2141796183 hasAuthorship W2141796183A5029531283 @default.
- W2141796183 hasAuthorship W2141796183A5030586237 @default.
- W2141796183 hasAuthorship W2141796183A5050526230 @default.
- W2141796183 hasAuthorship W2141796183A5060629326 @default.
- W2141796183 hasAuthorship W2141796183A5063941329 @default.
- W2141796183 hasAuthorship W2141796183A5083162341 @default.
- W2141796183 hasConcept C105696609 @default.
- W2141796183 hasConcept C109316439 @default.
- W2141796183 hasConcept C121608353 @default.
- W2141796183 hasConcept C134306372 @default.
- W2141796183 hasConcept C1491633281 @default.
- W2141796183 hasConcept C153911025 @default.
- W2141796183 hasConcept C185592680 @default.
- W2141796183 hasConcept C190283241 @default.
- W2141796183 hasConcept C197336794 @default.
- W2141796183 hasConcept C202751555 @default.
- W2141796183 hasConcept C2777366897 @default.
- W2141796183 hasConcept C2779321679 @default.
- W2141796183 hasConcept C2780783641 @default.
- W2141796183 hasConcept C29537977 @default.
- W2141796183 hasConcept C33923547 @default.
- W2141796183 hasConcept C502942594 @default.
- W2141796183 hasConcept C54355233 @default.
- W2141796183 hasConcept C55493867 @default.
- W2141796183 hasConcept C86803240 @default.
- W2141796183 hasConcept C95444343 @default.
- W2141796183 hasConcept C96232424 @default.
- W2141796183 hasConceptScore W2141796183C105696609 @default.
- W2141796183 hasConceptScore W2141796183C109316439 @default.